1990
DOI: 10.1016/0005-2736(90)90097-8
|View full text |Cite
|
Sign up to set email alerts
|

Kinetics of arginine-vasopressin uptake at the blood-brain barrier

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
49
0

Year Published

1993
1993
2017
2017

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 100 publications
(50 citation statements)
references
References 41 publications
1
49
0
Order By: Relevance
“…However, nutrients such as glucose, amino acids, and vitamins cross the BBB using specific transporters (48). Peptides in general poorly cross the BBB (49,50), but can be transported into the brain if specific transporters and/or receptors with a transport function are expressed in brain endothelium either under physiological (51,52) or pathological conditions, as in the case of RAGE and Aβ transport (43). Recent studies have independently confirmed earlier observations that circulating Aβ is an important precursor for brain Aβ (7,10,33) by demonstrating that peripheral Aβ can accelerate cerebral β-amyloidosis in a mouse model (11) and that liver serves as an important source of brain Aβ (53).…”
Section: Discussionmentioning
confidence: 99%
“…However, nutrients such as glucose, amino acids, and vitamins cross the BBB using specific transporters (48). Peptides in general poorly cross the BBB (49,50), but can be transported into the brain if specific transporters and/or receptors with a transport function are expressed in brain endothelium either under physiological (51,52) or pathological conditions, as in the case of RAGE and Aβ transport (43). Recent studies have independently confirmed earlier observations that circulating Aβ is an important precursor for brain Aβ (7,10,33) by demonstrating that peripheral Aβ can accelerate cerebral β-amyloidosis in a mouse model (11) and that liver serves as an important source of brain Aβ (53).…”
Section: Discussionmentioning
confidence: 99%
“…Early studies seemed to indicate that oxytocin and vasopressin, or at least physiologically significant amounts of these peptides, are excluded access to most regions of the CNS by the blood-brain barrier (BBB) (Ermisch et al, 1988;Meisenberg and Simmons, 1983b). However, more recently, a bidirectional saturable active transport mechanism across the BBB has been demonstrated for vasopressin (Banks et al, 1987;Zlokovic et al, 1990). The behavioral effects of peripherally circulating peptides may be indirect such as via the alteration of the BBB permeability to other substances.…”
Section: Discussionmentioning
confidence: 99%
“…Future studies are needed to determine if AVT treatment impacts behavior independently via effects on the brain or if the observed effects work primarily through its activation of the HPA axis and stimulation of corticosterone release. There is some indication, in mammals, that a small but measurable portion of peripherally administered radiolabelled-AVP can cross the blood-brain barrier (Zlokovic et al, 1990). While there have been several studies on the structure and permeability of the blood-brain barrier in the green anole (Kenny and Shivers, 1974;Shivers, 1979;Shivers and Harris, 1984), the specific permeability to AVT has not been examined.…”
Section: Research Articlementioning
confidence: 99%